204 related articles for article (PubMed ID: 20932483)
1. Should microbicides be controlled by women or by physicians?
Piret J; Bergeron MG
Int J Infect Dis; 2010 Sep; 14 Suppl 3():e14-7. PubMed ID: 20932483
[TBL] [Abstract][Full Text] [Related]
2. Recommendations for the development of vaginal microbicides. International Working Group on Vaginal Microbicides.
AIDS; 1996 Jul; 10(8):1-6. PubMed ID: 8828760
[TBL] [Abstract][Full Text] [Related]
3. AIDS in the Third World: how to stop the HIV infection?
De Clercq E
Verh K Acad Geneeskd Belg; 2007; 69(2):65-80. PubMed ID: 17550059
[TBL] [Abstract][Full Text] [Related]
4. Microbicides: putting women in control.
Forbes A
WORLD; 1998 Sep; (89):4-5. PubMed ID: 11365770
[TBL] [Abstract][Full Text] [Related]
5. Pharmaceutical development of microbicide drug products.
Friend DR
Pharm Dev Technol; 2010 Dec; 15(6):562-81. PubMed ID: 20017601
[TBL] [Abstract][Full Text] [Related]
6. Microbicides to prevent HIV transmission: overcoming obstacles to chemical barrier protection.
Dhawan D; Mayer KH
J Infect Dis; 2006 Jan; 193(1):36-44. PubMed ID: 16323129
[TBL] [Abstract][Full Text] [Related]
7. Vaginal microbicides to prevent human immunodeficiency virus infection in women: perspectives on the female genital tract, sexual maturity and mucosal inflammation.
Roberts L; Liebenberg L; Barnabas S; Passmore JA
Best Pract Res Clin Obstet Gynaecol; 2012 Aug; 26(4):441-9. PubMed ID: 22429786
[TBL] [Abstract][Full Text] [Related]
8. Advances in microbicide vaginal rings.
Malcolm RK; Edwards KL; Kiser P; Romano J; Smith TJ
Antiviral Res; 2010 Dec; 88 Suppl 1():S30-9. PubMed ID: 21109066
[TBL] [Abstract][Full Text] [Related]
9. Future strategies in microbicide development.
Rosenberg ZF; Devlin B
Best Pract Res Clin Obstet Gynaecol; 2012 Aug; 26(4):503-13. PubMed ID: 22406260
[TBL] [Abstract][Full Text] [Related]
10. Acceptability of a non-woven device for vaginal drug delivery of microbicides or other active agents.
Joanis CL; Hart CW
AIDS Behav; 2010 Jun; 14(3):600-6. PubMed ID: 20049522
[TBL] [Abstract][Full Text] [Related]
11. Specific microbicides in the prevention of HIV infection.
Kelly CG; Shattock RJ
J Intern Med; 2011 Dec; 270(6):509-19. PubMed ID: 21917029
[TBL] [Abstract][Full Text] [Related]
12. Novel approaches to vaginal delivery and safety of microbicides: biopharmaceuticals, nanoparticles, and vaccines.
Whaley KJ; Hanes J; Shattock R; Cone RA; Friend DR
Antiviral Res; 2010 Dec; 88 Suppl 1():S55-66. PubMed ID: 21109069
[TBL] [Abstract][Full Text] [Related]
13. Is HIV drug resistance a limiting factor in the development of anti-HIV NNRTI and NRTI-based vaginal microbicide strategies?
Martinez J; Coplan P; Wainberg MA
Antiviral Res; 2006 Sep; 71(2-3):343-50. PubMed ID: 16787667
[TBL] [Abstract][Full Text] [Related]
14. Inhibiting sexual transmission of HIV-1 infection.
Shattock RJ; Moore JP
Nat Rev Microbiol; 2003 Oct; 1(1):25-34. PubMed ID: 15040177
[TBL] [Abstract][Full Text] [Related]
15. Vaginal microbicides save money: a model of cost-effectiveness in South Africa and the USA.
Verguet S; Walsh JA
Sex Transm Infect; 2010 Jun; 86(3):212-6. PubMed ID: 20522634
[TBL] [Abstract][Full Text] [Related]
16. Sustained release of microbicides by newly engineered vaginal rings.
Saxena BB; Han YA; Fu D; Rathnam P; Singh M; Laurence J; Lerner S
AIDS; 2009 May; 23(8):917-22. PubMed ID: 19381077
[TBL] [Abstract][Full Text] [Related]
17. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
18. Combinatorial prevention of HIV transmission in women: the case for a vaginal microbicide.
Bélec L; Jenabian MA; Charpentier C; Saïdi H
Future Microbiol; 2011 Jul; 6(7):731-7. PubMed ID: 21797688
[TBL] [Abstract][Full Text] [Related]
19. Lack of effectiveness of cellulose sulfate gel for the prevention of vaginal HIV transmission.
Van Damme L; Govinden R; Mirembe FM; Guédou F; Solomon S; Becker ML; Pradeep BS; Krishnan AK; Alary M; Pande B; Ramjee G; Deese J; Crucitti T; Taylor D;
N Engl J Med; 2008 Jul; 359(5):463-72. PubMed ID: 18669425
[TBL] [Abstract][Full Text] [Related]
20. Microbicides and other topical agents in the prevention of HIV and sexually transmitted infections.
Nikolic DS; Garcia E; Piguet V
Expert Rev Anti Infect Ther; 2007 Feb; 5(1):77-88. PubMed ID: 17266456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
